Daily News Podcast

MDedge Daily News: Where the latest HCV drug combos fit in


 

The addition of the two latest treatment regimens for hepatitis C essentially closes the circle on treatment of this disease. Don’t shorten therapy for older, sicker cellulitis patients, apixaban and rivaroxaban reversal agent gets FDA approval, and do black women pay a price for hair care products?

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

CMS floats Medicare direct provider contracting
MDedge Dermatology
Absurdity
MDedge Dermatology
MDedge Daily News: Female physicans face enduring wage gap
MDedge Dermatology
MDedge Daily News: How Trump’s election affected contraception
MDedge Dermatology
What is an old doctor to do?
MDedge Dermatology
MDedge Daily News: Is ‘medical aid in dying’ suicide?
MDedge Dermatology
MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Dermatology
Teledermatology in the US Military: A Historic Foundation for Current and Future Applications
MDedge Dermatology
MDedge Daily News: How to handle opioid constipation
MDedge Dermatology
MDedge Daily News: Deep concern surrounding Title X changes
MDedge Dermatology